Lisa M. Eubanks

Scripps Research Institute — United States

Medicine · Health Sciences

23h-index1.9kcitations65works0.82yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Botulinum Toxin and Related Neurological Disorders(16), Forensic Toxicology and Drug Analysis(12), Neurological disorders and treatments(11), Hereditary Neurological Disorders(9), Neuropeptides and Animal Physiology(7)

Publications65 total

Fentanyl-Rewired: A 2-Azaspiro[3.3]heptane Core Preserves μ-Opioid Function
ACS Medicinal Chemistry Letters·2026Open Access
Bifunctional Behavior of Conformationally Constrained Methamphetamine Analogs: Unexpected Heteroclitic Immune Response and Antagonist Effects Altering Methamphetamine and Fentanyl Pharmacology
Journal of Medicinal Chemistry·2025
Solid-phase synthesis of a pyrrole library and identification of bioactive compounds
Bioorganic & Medicinal Chemistry Letters·2025Open Access
Bifunctional Inhibition of Botulinum Neurotoxin A Protease: Unexpected Active Site Inhibition Enhances Covalent Targeting of an Allosteric Site
Journal of Medicinal Chemistry·2025
Investigations of Thiosemicarbazides as Botulinum Toxin Active-Site Inhibitors: Enzyme, Cellular, and Rodent Intoxication Studies
ACS Infectious Diseases·2024· 3 citedOpen Access
Evaluation of a hapten conjugate vaccine against the “zombie drug” xylazine
Chemical Communications·2024· 2 cited
An Engineered Human-Antibody Fragment with Fentanyl Pan-Specificity That Reverses Carfentanil-Induced Respiratory Depression
ACS Chemical Neuroscience·2023· 15 citedOpen Access
Development of a vaccine against the synthetic opioid U-47700
Frontiers in Pharmacology·2023· 2 citedOpen Access
An Engineered Human-Antibody Fragment with Fentanyl Pan-Specificity that Reverses Carfentanil-Induced Respiratory Depression
2023· 3 citedOpen Access
Preclinical Assessment of CSX-1004: A High Affinity, Humanized Monoclonal Antibody for Mitigating the Effects of Fentanyl
Journal of Pharmacology and Experimental Therapeutics·2023Open Access
Catalytic Antibody Blunts Carfentanil-Induced Respiratory Depression
ACS Pharmacology & Translational Science·2023· 12 citedOpen Access
Demystifying the Druggability of the MYC Family of Oncogenes
Journal of the American Chemical Society·2023· 38 citedOpen Access
Development of an Effective Monoclonal Antibody against Heroin and Its Metabolites Reveals Therapies Have Mistargeted 6-Monoacetylmorphine and Morphine over Heroin
ACS Central Science·2022· 10 citedOpen Access
Polyphosphazene: A New Adjuvant Platform for Cocaine Vaccine Development
Molecular Pharmaceutics·2022· 11 cited
Investigation of Salicylanilides as Botulinum Toxin Antagonists
ACS Infectious Diseases·2022· 4 citedOpen Access
A Vaccine against Benzimidazole-Derived New Psychoactive Substances That Are More Potent Than Fentanyl
Journal of Medicinal Chemistry·2022· 12 cited
Salicylanilides Reduce SARS-CoV-2 Replication and Suppress Induction of Inflammatory Cytokines in a Rodent Model
ACS Infectious Diseases·2021· 20 cited
Pharmacokinetic Approach to Combat the Synthetic Cannabinoid PB-22
ACS Chemical Neuroscience·2021· 6 cited
Synthetic fluorescent MYC probe: Inhibitor binding site elucidation and development of a high-throughput screening assay
Bioorganic & Medicinal Chemistry·2021· 8 citedOpen Access
Improvements on a chemically contiguous hapten for a vaccine to address fentanyl-contaminated heroin
Bioorganic & Medicinal Chemistry·2021· 9 cited
page 1 of 4Next →

Frequent Co-authors

Kim D. Janda(44), Beverly A. Ellis(12), Tobin J. Dickerson(10), Bin Zhou(9), Mark S. Hixon(6), Steven Blake(6), William H. Tepp(5), Mingliang Lin(5), Eric A. Johnson(4), Sabine Pellett(4), C. Dale Poulter(4), Daniel Globisch(4), Paul T. Bremer(4), Jinny Claire Lee(4), Joel E. Schlosburg(3), Ian A. Wilson(3), Ryan J. Shirey(3), Yoshihiro Natori(3), Claude J. Rogers(2), George F. Koob(2)